As markers of such an immune response we analyzed shrinkage of tumor spheroids, CD80/CD86 expression on antigen-presenting cells (APCs), and granzyme B (GrB) expression by CTLs [18, 19]. This evidence concerns the gene GZMB and neoplasm.